Weight loss drugs containing GLP-1 agonists have exploded in popularity in recent years, gaining the interest of consumers for usage far beyond the FDA-approved purpose to treat type 2 diabetes and obesity. This widespread and off-label interest in weight loss drugs has also led to an explosion of unapproved products available online and via social media, which do come with safety risks for consumers. While GLP-1s are currently permitted in sport, it’s important for athletes to know […]

Glucagon-like peptide-1 agonism – GLP-1, common in obesity medicines – is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences. This research represents a potential alternative obesity treatment, as it could make peptide-containing medicines more tolerable and easier to employ for a large pool of patients by eliminating unfavorable gastrointestinal side effects. In a report published in Molecular Metabolism in April 2026, DiMarchi […]

Medi-Weightloss, which offers medically supervised weight loss programs, opened a Georgetown clinic in early April. The gist Services available include GLP-1 medications, diabetes treatment, IV therapy, vitamin and nutrient injections, and more. The location offers a free in-person health assessment with no commitment required. Owner Shankar Bellam said patients describe the team as encouraging and investing in real, lasting results—not just the number on the scale. Medi-Weightloss has 136 locations nationwide, including another Central Texas clinic in […]

Basically, your plate can look just as full, but it’s built around foods with higher water and fiber content—like soups, fruits, vegetables, beans, yogurt, oats, stews—rather than filled with calorie-dense options, brownies, chips, high-fat cheeses, and spreads like peanut butter. A 2025 study in the American Journal of Clinical Nutrition similarly suggests that when people eat primarily whole or minimally processed foods, they can often consume a larger volume while taking in fewer calories than on an […]

A blanket refusal to cover weight-loss medication like GLP-1s is no longer allowed under Washington state law, an appeals court ruled last week. Many health insurances do not provide coverage to weight-loss medication. In years past, weight-loss drugs have been ineffective and expensive with many side effects. That may be changing with the advent of GLP-1 medication like Ozempic, Wegovy or mounjaro. Glucagon-like peptide-1 is a naturally occurring hormone within the body that regulates insulin uptake. The […]

Once people understood glucagonlike peptide 1 (GLP-1) drugs’ potential for weight loss, the race among pharmaceutical companies was on. Among the current options, Wegovy can help people lose an average of 10 percent of their body weight in a year, while people taking Zepbound have had about a 15 percent loss, on average, in the same period. Soon the most powerful GLP-1 treatment to date could hit the market: retatrutide. Already popular on the online peptide gray […]

Two of the hottest trends in health — longevity medicine and weight-loss drugs — are colliding. A theory that GLP-1 medications like Ozempic or Zepbound might help people live longer has been bandied about by biohackers and aging researchers for several years. Online pharmacies already market compounded versions of the drugs to purportedly extend health span. But so far, academic research into the hypothesis has been scant. One of the first studies putting the idea to the […]